Copaxone (glatiramer acetate)

pCPA File Number: 20991
Negotiation Status:
Concluded without agreement
Indication(s):
Clinically Isolated Syndrome
Sponsor/Manufacturer:
Teva Canada Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: